Is Diovan HCT Safe During Pregnancy? -- An Overview
Diovan HCT and Pregnancy Categories C and D
The U.S. Food and Drug Administration (FDA) categorizes Diovan HCT as a pregnancy Category C medicine for the
first trimester and a pregnancy Category D medicine for the second and
third trimesters.
The FDA uses a pregnancy category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that show side effects to the fetus in animal studies, but for which no human studies in pregnant women have been done. Pregnancy Category D is given to medicines that have shown clear evidence of risk to the fetus in the studies. Pregnancy Category D is a stronger warning than a pregnancy Category C classification. Despite these warnings, a pregnancy Category C or D medicine may still be given to a pregnant woman if her healthcare provider believes that its benefits outweigh the possible risks to the unborn child.
What Is the Risk of Using Diovan HCT During Pregnancy?
Some of the complications sometimes seen in fetuses or newborns exposed to Diovan HCT during pregnancy include:
- Low blood pressure (hypotension)
- Developmental problems with the nervous system
- Developmental problems with the cardiovascular system (this includes the heart and/or blood vessels)
- Developmental problems with the lungs
- Kidney failure
- Deformities of the head and face
- Jaundice (yellowing of the skin or the whites of the eyes)
- Loss of life.